QNCX logo

Quince Therapeutics (QNCX) Working Capital

Annual Working Capital

$67.87 M
-$22.81 M-25.16%

December 31, 2023


Summary


Performance

QNCX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherQNCXbalance sheetmetrics:

Quarterly Working Capital

$46.29 M
-$6.82 M-12.85%

September 30, 2024


Summary


Performance

QNCX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherQNCXbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

QNCX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.2%-31.8%
3 y3 years-43.9%-31.8%
5 y5 years-4.6%-31.8%

QNCX Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-30.4%at low-52.5%at low
5 y5-year-43.9%at low-70.2%at low
alltimeall time-43.9%+1075.4%-70.2%at low

Quince Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$46.29 M(-12.8%)
Jun 2024
-
$53.12 M(-12.3%)
Mar 2024
-
$60.60 M(-10.7%)
Dec 2023
$67.87 M(-25.2%)
$67.87 M(-18.2%)
Sep 2023
-
$82.92 M(-4.2%)
Jun 2023
-
$86.60 M(-3.1%)
Mar 2023
-
$89.38 M(-1.4%)
Dec 2022
$90.68 M(-6.9%)
$90.68 M(-2.8%)
Sep 2022
-
$93.33 M(-0.1%)
Jun 2022
-
$93.42 M(+7.8%)
Mar 2022
-
$86.64 M(-11.1%)
Dec 2021
$97.45 M
$97.45 M(-7.4%)
DateAnnualQuarterly
Sep 2021
-
$105.27 M(-10.3%)
Jun 2021
-
$117.31 M(-11.1%)
Mar 2021
-
$132.02 M(+9.2%)
Dec 2020
$120.87 M(+24.4%)
$120.87 M(-4.5%)
Sep 2020
-
$126.56 M(-8.2%)
Jun 2020
-
$137.91 M(-11.3%)
Mar 2020
-
$155.48 M(+60.0%)
Dec 2019
$97.16 M(+36.6%)
$97.16 M(-17.8%)
Sep 2019
-
$118.24 M(-6.6%)
Jun 2019
-
$126.62 M(+111.8%)
Mar 2019
-
$59.78 M(-16.0%)
Dec 2018
$71.13 M(+1131.8%)
$71.13 M
Dec 2017
$5.77 M
-

FAQ

  • What is Quince Therapeutics annual working capital?
  • What is the all time high annual working capital for Quince Therapeutics?
  • What is Quince Therapeutics annual working capital year-on-year change?
  • What is Quince Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Quince Therapeutics?
  • What is Quince Therapeutics quarterly working capital year-on-year change?

What is Quince Therapeutics annual working capital?

The current annual working capital of QNCX is $67.87 M

What is the all time high annual working capital for Quince Therapeutics?

Quince Therapeutics all-time high annual working capital is $120.87 M

What is Quince Therapeutics annual working capital year-on-year change?

Over the past year, QNCX annual working capital has changed by -$22.81 M (-25.16%)

What is Quince Therapeutics quarterly working capital?

The current quarterly working capital of QNCX is $46.29 M

What is the all time high quarterly working capital for Quince Therapeutics?

Quince Therapeutics all-time high quarterly working capital is $155.48 M

What is Quince Therapeutics quarterly working capital year-on-year change?

Over the past year, QNCX quarterly working capital has changed by -$21.57 M (-31.79%)